Startup profile · funding coverage
Maven funding, valuation and investors
Virtual clinic for women's and family health — fertility, maternity, pediatrics, and menopause.
Keep track of Maven
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series F
$125M · October 2024
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$125M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, New York
Investors in latest funding
Other: Sequoia , General Catalyst , Lux Capital , Andreessen Horowitz
Overview
Maven Clinic is a virtual healthcare platform specializing in women's and family health, including fertility, pregnancy, pediatrics, and menopause care. Employers offer Maven as a benefit connecting members with providers via video and messaging. Founded by Kate Ryder, Maven raised a $125M Series F in October 2024 with Sequoia, General Catalyst, Lux Capital, and Andreessen Horowitz among participants, bringing total funding above $425M.
Why Maven is interesting
Maven became the largest virtual women's-health clinic with $425M+ raised — a16z joined a cap table including Sequoia and General Catalyst as employers adopted Maven as family-benefits infrastructure.
Product & use cases
Maven provides employer-sponsored virtual care across the family health journey: fertility consultations, maternity coaching, pediatric support, and menopause management — with dedicated care advocates and provider networks.
- Employers offering fertility and maternity benefits to improve retention and reduce healthcare costs
- Members accessing OB-GYNs, fertility specialists, and lactation consultants via app
- HR teams reporting on family-health benefit utilization and outcomes
Key facts
- Series F (Oct 2024): $125M; total funding $425M+ (PR Newswire)
- Largest virtual clinic focused on women's and family health
- Employer benefits platform covering fertility through menopause
- Founded 2014 by Kate Ryder
Funding history (newest first)
Investors in our directory
Funds linked from Maven's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Maven built the category-defining employer benefit for women's health before incumbents reacted — network depth across fertility-to-pediatrics creates switching costs for enterprise buyers.
Employer-sponsored women's health went from perk to retention necessity. Maven's scale ($425M+ raised) reflects category leadership but incumbents and point-solution fertility vendors keep enterprise RFPs competitive.
-
Teladoc / major telehealth incumbent
General telehealth adding women's health modules; Maven's specialized vertical depth.
-
Progyny adjacent
Fertility benefits manager; narrower focus vs Maven's full family health span.
-
Carrot Fertility direct
Employer fertility benefits competitor; overlaps on fertility but less maternity/pediatrics breadth.
Notable stories
- Kate Ryder founded Maven after seeing friends struggle to navigate fertility and maternity care — building employer benefits before 'women's health' was standard in corporate wellness packages.
- Maven's Series F during 2024 reflected continued employer demand for family benefits despite broader digital health funding slowdown.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Maven's financing or category context.
FAQs about Maven
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.